Vontobel Holding’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Vontobel Holding’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,000	Closed	-$226K	–	1132
2022 Q2	$226K	Buy	+3,000	New	+$133K	﹤0.01%	913
2021 Q3	–	Sell	-4,762	Closed	-$372K	–	1245
2021 Q2	$372K	Buy	4,762 +2,412	+103%	+$178K	﹤0.01%	853
2021 Q1	$222K	Sell	2,350 -765	-25%	-$91K	﹤0.01%	891
2020 Q4	$436K	Buy	+3,115	New	+$341K	﹤0.01%	691

Vontobel Holding's TPTX Position: Q3 2022 in Review

Vontobel Holding sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 3,000 shares — an estimated $226K sold.

Vontobel Holding first reported a position in TPTX in Q4 2020 and held it in 4 quarters. The position peaked at $436K in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Vontobel Holding reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Vontobel Holding sold 3,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $226K.
Vontobel Holding first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Vontobel Holding's Turning Point Therapeutics, Inc. Common Stock position peaked at $436K in Q4 2020.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Vontobel Holding's 13F filing for Q3 2022, filed 4 Nov 2022.